Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Primary Open-angle Glaucoma, Ocular Hypertension

In brief

This is a study of the safety, tolerability, pharmacokinetics (measurement of drug levels in the blood), and intraocular pressure lowering effects of OPA-6566 ophthalmic solution in subjects with primary open-angle glaucoma or ocular hypertension.

Key facts

Study ID

NCT01410188

Run by

Kubota Vision Inc.

People needed

160

Starts

2011-09-01

Expected to finish

2012-10-01

Last updated by the study team

2014-03-11

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diagnosis of bilateral primary open-angle glaucoma
• diagnosis of ocular hypertension as defined in the protocol

You may not qualify if…

• any form of glaucoma other than primary open-angle glaucoma in either eye
• other ocular conditions as defined by the protocol

Where it is running

• Study site — Artesia, California, United States
• Study site — Glendale, California, United States
• Study site — Roswell, Georgia, United States
• Study site — Louisville, Kentucky, United States
• Study site — Washington, Missouri, United States
• Study site — High Point, North Carolina, United States
• Study site — Maryville, Tennessee, United States
• Study site — Austin, Texas, United States
• Study site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.